查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595065

微生物組定序服務的全球市場

Microbiome Sequencing Services
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球微生物組定序服務市場將達到 55 億美元

微生物組定序服務的全球市場預計 2023 年為 17 億美元，預計到 2030 年將達到 55 億美元，在 2023-2030 年分析期間複合年成長率為 18.1%。合成技術是本報告分析的細分市場之一，預計複合年成長率為 16.8%，到分析期結束時將達到 23 億美元。分析期間，連接技術領域的複合年成長率預計為14.7%。

美國市場預估為4.762億美元，中國預期複合年成長率為17.3%

預計 2023 年美國微生物組定序服務市場規模將達 4.762 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到8.421億美元，2023-2030年分析期間複合年成長率為17.3%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 15.8% 和 15.5%。在歐洲，德國的複合年成長率預計約為 13.2%。

全球微生物組定序服務市場—主要趨勢與促進因素總結

什麼是微生物組定序服務？

微生物組定序服務利用先進的定序技術來分析和表徵人體、土壤、水和植物等各種環境中存在的微生物群落。這些服務提供了對微生物組的組成、多樣性和功能的詳細了解，微生物組由細菌、病毒、真菌和其他微生物組成。我們使用 16S rRNA 定序、鳥槍法宏基因組學和全基因組定序等技術來破解微生物的遺傳物質，以揭示它們在健康、疾病、農業和環境中的作用。

微生物組分析的重要性在於其能夠揭示微生物在人類健康、疾病預防、營養、農業和生態系統平衡中所扮演的重要角色。在醫療保健領域，微生物組分析為個人化醫療和開發針對胃腸道疾病、代謝性疾病、自體免疫疾病甚至精神疾病等疾病的標靶治療鋪平了道路。在農業中，它有助於改善土壤健康、作物產量和植物抗病性。隨著我們對微生物組的理解不斷進步，研究正在成為臨床研究和環境管理的重要工具。

技術進步如何形塑微生物組定序服務市場？

技術進步大大提高了微生物組定序服務的準確性、速度和成本效益，推動了醫療保健、農業和環境科學領域的創新。關鍵進展之一是採用下一代定序 (NGS)平台，該平台以低成本提供高通量、快速定序功能。 Illumina定序、Oxford Nanopore 定序和 PacBio 定序等NGS 技術可提供對微生物多樣性和功能的詳細了解，從而能夠對複雜微生物組進行更全面的分析。這擴大了微生物組定序在個人化醫療、藥物開發和診斷的應用。

鳥槍法宏基因組學的興起進一步提高了微生物組定序服務的能力。與標靶 16S rRNA 定序不同，鳥槍法宏基因組學對樣本中的所有遺傳物質進行定序，從而可以更詳細地了解微生物組成，包括已知物種和新物種。它還提供功能見解，例如微生物代謝途徑和基因表現。這對於了解微生物組如何影響健康、疾病和生態系統平衡至關重要。該技術有助於闡明微生物在免疫調節、營養吸收和藥物代謝中的作用，支持臨床研究和治療開發。

生物資訊學和資料分析的進步也在塑造微生物組定序市場方面發揮關鍵作用。強大的生物資訊工具和機器學習演算法使研究人員能夠處理大量序列資料，識別微生物分類群，預測功能途徑，並將微生物組概況與特定的健康狀況和環境參數相關聯，現在您可以做到。這改善了複雜微生物組資料的解釋，使定序服務對於臨床、農業和生態學應用更加實用和有用。此外，雲端基礎的平台的發展使得共用、儲存和分析微生物組資料變得更加容易，從而實現全球協作和更有效率的研究。這些創新不僅擴展了微生物組定序服務的能力，而且符合精準醫療、永續農業和環境監測等更廣泛的趨勢。

微生物組定序服務在各領域有哪些新應用？

由於需要更深入地了解微生物在健康、疾病、農業和環境永續性中的作用，微生物組定序服務正在擴大其在各個領域的應用。在醫療保健領域，微生物組定序用於研究人類微生物組，特別是腸道、皮膚、口腔和呼吸道。這使得開發針對大腸激躁症（IBS）、肥胖、糖尿病和發炎性腸道疾病（IBD）等疾病的個人化治療成為可能。對腸道微生物群進行定序可以識別益生菌、益生元和飲食干預的目標有益細菌，從而實現個人化營養和腸道健康管理。

在製藥業，微生物組序列分析用於藥物發現和藥物開發。透過分析微生物組如何影響藥物代謝和患者反應，製藥公司可以開發更有針對性的治療方法並減少副作用。這種方法對於開發基於微生物組的療法特別有用，該療法使用活細菌和微生物代謝物來治療困難梭狀芽孢桿菌傳染病、潰瘍性大腸炎和異位性皮膚炎等疾病。微生物組的序列分析也透過識別可用作抗原的微生物成分來支持疫苗開發，有助於預防感染疾病。

在農業中，微生物組定序用於提高作物產量、改善土壤健康以及開發植物病害生物防治劑。幫助辨識有益的土壤微生物，增強養分吸收、促進植物生長並抑制病原生物。定序服務可以創建微生物群落，將其添加到土壤和種子中，以提高作物性能和復原力，並支持永續農業實踐。在環境領域，微生物組序列分析支持利用微生物分解土壤和水中污染物的生物修復工作。它還透過分析由於污染、氣候變遷和棲息地破壞等因素造成的微生物多樣性變化來支持生態系統監測。微生物組定序的不斷成長的應用領域凸顯了微生物組定序在推動創新、改善結果和支持人類健康和環境永續性方面的重要性。

微生物組定序服務市場成長的驅動力是什麼？

微生物組定序服務市場的成長受到多種因素的推動，包括個人化醫療需求的增加、微生物組研究投資的增加以及定序技術的進步。主要成長要素之一是人們對人類微生物組及其對健康和疾病影響的興趣日益濃厚。隨著微生物組組成與各種健康狀況之間的關係不斷被闡明，臨床和研究環境中對微生物組定序的需求正在增加。這種需求在腸道健康等領域尤其強勁，其中針對微生物組的治療和診斷正在成為精準醫學的主流。

微生物組研究投資的增加進一步推動了對定序服務的需求。政府、製藥公司和生技公司正在大力投資微生物組計劃，以支持新藥、益生菌和診斷工具的開發。此外，專注於抗菌素抗藥性、腸道健康和代謝疾病的公共衛生舉措正在導致微生物組研究的資金增加，從而推動了對提供詳細微生物見解的測序服務的需求。

定序技術和生物資訊學的進步也促進了市場的成長。高通量、經濟高效的測序平台的開發使研究人員、醫療保健提供者和農業相關企業更容易獲得微生物組測序。生物資訊工具的改進增強了對複雜微生物組資料的解釋，使得更容易將定序結果轉化為臨床、農業和環境應用的可行見解。此外，消費者微生物組測試的興起提高了公眾對個人微生物組分析的認知和興趣，並支持了消費者健康和保健市場的成長。

隨著定序、資料分析和基於微生物組的治療方法技術創新的進步，微生物組定序服務市場有望強勁成長。這些趨勢，加上對精準醫療、永續農業和環境監測不斷成長的需求，使得微生物組定序成為促進人類健康、提高農業生產力和支持各部門生態系統平衡的一個重要組成部分。 。

部分

應用（製藥、學術/研究機構、生物技術）；技術（合成、連接、焦磷酸測序、桑格測序和其他技術）

受訪企業範例（44家知名企業）

  • AnimalBiome
  • Arranta Bio
  • BIOHM
  • Biom Pharmaceutical Corporation
  • BioMathematica
  • BiomeSense
  • Biomesight
  • BIOMx
  • Biose Industry
  • Biotage AB

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP16589

Global Microbiome Sequencing Services Market to Reach US$5.5 Billion by 2030

The global market for Microbiome Sequencing Services estimated at US$1.7 Billion in the year 2023, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 18.1% over the analysis period 2023-2030. Synthesis Technique, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Ligation Technique segment is estimated at 14.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$476.2 Million While China is Forecast to Grow at 17.3% CAGR

The Microbiome Sequencing Services market in the U.S. is estimated at US$476.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$842.1 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.8% and 15.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global Microbiome Sequencing Services Market - Key Trends & Drivers Summarized

What Are Microbiome Sequencing Services, and Why Are They So Crucial in Modern Genomics and Healthcare?

Microbiome Sequencing Services involve the use of advanced sequencing technologies to analyze and characterize the microbial communities found in various environments, including the human body, soil, water, and plants. These services provide detailed insights into the composition, diversity, and function of microbiomes, which consist of bacteria, viruses, fungi, and other microorganisms. Technologies like 16S rRNA sequencing, shotgun metagenomics, and whole-genome sequencing are used to decode the genetic material of microbes, uncovering their roles in health, disease, agriculture, and the environment.

The importance of microbiome sequencing lies in its ability to reveal the critical roles that microbes play in human health, disease prevention, nutrition, agriculture, and ecological balance. In healthcare, microbiome analysis has paved the way for personalized medicine, enabling the development of targeted therapies for conditions like gastrointestinal diseases, metabolic disorders, autoimmune diseases, and even mental health conditions. In agriculture, it helps improve soil health, crop yield, and plant disease resistance. As the understanding of microbiomes advances, microbiome sequencing services are becoming essential tools in both clinical research and environmental management.

How Are Technological Advancements Shaping the Microbiome Sequencing Services Market?

Technological advancements have significantly enhanced the accuracy, speed, and cost-effectiveness of Microbiome Sequencing Services, driving innovation across healthcare, agriculture, and environmental sciences. One of the major developments is the adoption of next-generation sequencing (NGS) platforms, which offer high-throughput, rapid sequencing capabilities at a lower cost. NGS technologies, including Illumina sequencing, Oxford Nanopore sequencing, and PacBio sequencing, provide detailed insights into microbial diversity and function, enabling more comprehensive analysis of complex microbiomes. This has expanded the use of microbiome sequencing in personalized medicine, drug development, and diagnostics.

The rise of shotgun metagenomics has further improved the capabilities of microbiome sequencing services. Unlike targeted 16S rRNA sequencing, shotgun metagenomics sequences all genetic material in a sample, allowing for a more detailed view of microbial composition, including both known and novel species. It also provides functional insights, such as microbial metabolic pathways and gene expression profiles, which are crucial for understanding how microbiomes influence health, disease, and ecological balance. This technology has been instrumental in uncovering microbial roles in immune modulation, nutrient absorption, and drug metabolism, supporting both clinical research and therapeutic development.

Advancements in bioinformatics and data analytics have also played a key role in shaping the microbiome sequencing market. Powerful bioinformatics tools and machine learning algorithms now enable researchers to process large volumes of sequencing data, identify microbial taxa, predict functional pathways, and correlate microbiome profiles with specific health conditions or environmental parameters. This has improved the interpretation of complex microbiome data, making sequencing services more actionable and valuable for clinical, agricultural, and ecological applications. Additionally, the development of cloud-based platforms has facilitated the sharing, storage, and analysis of microbiome data, enabling global collaboration and more efficient research. These technological innovations not only expand the capabilities of microbiome sequencing services but also align with broader trends toward precision medicine, sustainable agriculture, and environmental monitoring.

What Are the Emerging Applications of Microbiome Sequencing Services Across Different Sectors?

Microbiome Sequencing Services are finding expanding applications across various sectors, driven by the need for deeper insights into microbial roles in health, disease, agriculture, and environmental sustainability. In the healthcare sector, microbiome sequencing is used to study the human microbiome, particularly in the gut, skin, oral cavity, and respiratory tract. It enables the development of personalized treatments for conditions like irritable bowel syndrome (IBS), obesity, diabetes, and inflammatory bowel disease (IBD). Sequencing the gut microbiome helps identify beneficial bacteria that can be targeted with probiotics, prebiotics, and dietary interventions, supporting personalized nutrition and gut health management.

In the pharmaceutical industry, microbiome sequencing is used in drug discovery and development. By analyzing how microbiomes influence drug metabolism and patient response, pharmaceutical companies can develop more targeted therapies and reduce adverse drug reactions. This approach is particularly valuable in the development of microbiome-based therapeutics, which use live bacteria or microbial metabolites to treat conditions like Clostridioides difficile infection, ulcerative colitis, and atopic dermatitis. Microbiome sequencing also supports the development of vaccines by identifying microbial components that can be used as antigens, contributing to infectious disease prevention.

In the agriculture sector, microbiome sequencing is used to enhance crop yield, improve soil health, and develop biocontrol agents for plant diseases. It helps identify beneficial soil microbes that promote nutrient absorption, enhance plant growth, and suppress pathogenic organisms. Sequencing services enable the creation of microbial consortia, which are added to soil or seeds to improve crop performance and resilience, supporting sustainable farming practices. In the environmental sector, microbiome sequencing aids in bioremediation efforts, where microbes are used to break down pollutants in soil and water. It also supports ecosystem monitoring by analyzing changes in microbial diversity due to factors like pollution, climate change, and habitat destruction. The expanding applications of microbiome sequencing across these sectors highlight its critical role in driving innovation, improving outcomes, and supporting sustainability in both human health and the environment.

What Drives Growth in the Microbiome Sequencing Services Market?

The growth in the Microbiome Sequencing Services market is driven by several factors, including increasing demand for personalized medicine, rising investments in microbiome research, and technological advancements in sequencing. One of the primary growth drivers is the growing interest in the human microbiome and its impact on health and disease. As research continues to uncover links between microbiome composition and various health conditions, there is increasing demand for microbiome sequencing in both clinical and research settings. This demand is particularly strong in areas like gut health, where microbiome-targeted therapies and diagnostics are becoming mainstream in precision medicine.

Rising investments in microbiome research have further fueled demand for sequencing services. Governments, pharmaceutical companies, and biotechnology firms are investing heavily in microbiome projects, supporting the development of new drugs, probiotics, and diagnostic tools. In addition, public health initiatives focusing on antimicrobial resistance, gut health, and metabolic disorders have led to increased funding for microbiome studies, boosting demand for sequencing services that provide detailed microbial insights.

Advancements in sequencing technologies and bioinformatics have also contributed to market growth. The development of high-throughput, cost-effective sequencing platforms has made microbiome sequencing more accessible to researchers, healthcare providers, and agritech firms. Improved bioinformatics tools have enhanced the interpretation of complex microbiome data, making it easier to translate sequencing results into actionable insights for clinical, agricultural, and environmental applications. Additionally, the rise of direct-to-consumer microbiome testing has increased public awareness and interest in personal microbiome analysis, supporting market growth in consumer health and wellness.

With ongoing innovations in sequencing, data analytics, and microbiome-based therapeutics, the microbiome sequencing services market is poised for robust growth. These trends, combined with increasing demand for precision medicine, sustainable agriculture, and environmental monitoring, make microbiome sequencing a vital component of modern scientific and clinical strategies focused on improving human health, enhancing agricultural productivity, and supporting ecological balance across various sectors.

SCOPE OF STUDY:

The report analyzes the Microbiome Sequencing Services market in terms of US$ Thousand by the following End-Use; Technique, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceutical, Academic & Research Institutes, Biotech); Technique (Synthesis, Ligation, Pyrosequencing, Sanger Sequencing, Other Techniques)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • AnimalBiome
  • Arranta Bio
  • BIOHM
  • Biom Pharmaceutical Corporation
  • BioMathematica
  • BiomeSense
  • Biomesight
  • BIOMx
  • Biose Industry
  • Biotage AB

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Microbiome Sequencing Services - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Research on Gut Health Sets the Stage for Microbiome Analysis
    • Rising Incidences of Chronic Diseases Spur Demand for Microbiome Sequencing
    • Expanding Use in Cancer Research Generates Market Opportunities
    • Enhanced Accuracy and Speed of Sequencing Drives Adoption in Healthcare
    • Strong Investment in Genomics Research Crucial for Market Growth
    • Use in Drug Development Expands Microbiome Sequencing Market
    • Rising Demand for Functional Foods and Probiotics Propels Sequencing Adoption
    • Integration with AI for Predictive Analysis Strengthens Business Case
    • Expanding Applications in Dermatology Generate Demand for Sequencing Services
    • Growing Interest in Gut-Brain Axis Research Fuels Microbiome Sequencing Demand
    • Increasing Use in Nutrigenomics Generates Market Opportunities
    • Expanding Role in Infectious Disease Research Drives Sequencing Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microbiome Sequencing Services Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Synthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Ligation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Ligation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pyrosequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Pyrosequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Sanger Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Sanger Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • JAPAN
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Japan 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Japan 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • CHINA
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 34: China Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: China 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • EUROPE
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • FRANCE
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 42: France Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: France 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 44: France Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • GERMANY
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Germany 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Germany 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Italy 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • UNITED KINGDOM
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 54: UK Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: UK 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 56: UK Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of World 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of World 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030

IV. COMPETITION